KUFSTEIN, Austria, June 20 (Reuters) – Switzerland’s
Novartis pledged to nearly triple its number of
biosimilar drugs on the market by 2020, raising its bet that
cheaper versions of blockbuster…
The post Novartis aims to nearly triple biosimilar drugs on market by 2020 appeared first on NASDAQ.